Eris Lifesciences Limited — Call Transcript 2021

Oct 22, 2021

==> picture [596 x 69] intentionally omitted <==

==> picture [596 x 69] intentionally omitted <==

Date: 22[nd] October, 2021

To BSE Limited Phiroze Jeejeebhoy Towers Dalal Street Mumbai- 400001	To National Stock Exchange of India Limited Exchange Plaza Bandra Kurla Complex Bandra (E) Mumbai-400051
Security Code: 540596	Symbol: ERIS

SUBJECT: INTIMATION OF SCHEDULE OF ANALYST & INVESTOR CALL PURSUANT TO REGULATION 30 AND OTHER APPLICABLE REGULATIONS OF THE SECURITIES AND EXCHANGE BOARD OF INDIA (LISTING OBLIGATIONS AND DISCLOSURE REQUIREMENTS) REGULATIONS, 2015 (SEBI LODR, 2015)

Dear Sir/Madam,

We wish to inform that pursuant to regulation 30 and other applicable regulations, if any, of the SEBI LODR, 2015, the Company will hold a conference call for analysts and investors on Friday, 29[th] October, 2021, after declaration of the standalone and consolidated unaudited financial results of the Company for the quarter and half year ended 30[th] September, 2021. The details of the said call are attached herewith and also available on Company’s website.

Thanking you.

For Eris Lifesciences Limited

==> picture [65 x 55] intentionally omitted <==

_______ Milind Talegaonkar Company Secretary and Compliance Officer Membership No.: A26493

Encl.:a/a

==> picture [596 x 4] intentionally omitted <==

==> picture [596 x 4] intentionally omitted <==

==> picture [596 x 4] intentionally omitted <==

==> picture [596 x 4] intentionally omitted <==

==> picture [596 x 4] intentionally omitted <==

==> picture [596 x 4] intentionally omitted <==

==> picture [596 x 4] intentionally omitted <==

==> picture [596 x 4] intentionally omitted <==

==> picture [596 x 4] intentionally omitted <==

==> picture [596 x 4] intentionally omitted <==

==> picture [596 x 4] intentionally omitted <==

==> picture [596 x 4] intentionally omitted <==

==> picture [596 x 4] intentionally omitted <==

==> picture [596 x 4] intentionally omitted <==

==> picture [596 x 4] intentionally omitted <==

==> picture [596 x 5] intentionally omitted <==

==> picture [596 x 4] intentionally omitted <==

==> picture [596 x 4] intentionally omitted <==

==> picture [596 x 4] intentionally omitted <==

==> picture [596 x 4] intentionally omitted <==

==> picture [596 x 4] intentionally omitted <==

==> picture [101 x 58] intentionally omitted <==

The Senior Management Team of

Eris Lifesciences Limited

Cordially invites you to its

Earnings Conference Call

To discuss the financial and operational performance for

Q2 & H1 FY22

Day/Date: Friday, 29[th] October, 2021

Time: 4:00 PM, IST

Option 1: Express Join with Diamond Pass[TM]

 Pre-register with the below link and join without waiting for the operator:

https://services.choruscall.in/DiamondPassRegistration/register?confirmationNumber=3666277&linkSecurityString=ddd5159fa

Option 2: Join through below Dial-In Numbers

Access Numbers

Primary Number:

+91 22 6280 1472 +91 22 7115 8839

USA: 1 866 746 2133 UK: 0 808 101 1573 Singapore: 800 101 2045 Hong Kong: 800 964 448 Argentina: 008 001 424 3444 Australia: 180 005 3698 Belgium: 008 001 424 3444 Canada: 0 118 001 424 3444 China: 400 842 8405 International Toll Free Number: France: 080 091 4745 Germany: 008 001 424 3444 Italy: 008 001 424 3444 Japan: 005 311 61110 Netherlands: 0 800 022 9808 Poland: 0 0800 112 4248 South Korea: 0 018 001 424 3444 Sweden: 008 001 424 3444 Switzerland: 080 056 1863 Thailand: 0 018 001 424 3444

We look forward to your participation

___________

RSVP:

Kruti Raval: +91 99090 17419